China, Oct. 29 -- China based Shanghai Yuxin Biotechnology Co., Ltd. has secured contract from SHANGHAI GONGLI HOSPITAL for Procurement of 0811-254DSITC2681 Extracorporeal shock wave cardiovascular therapy system(1). The value of the contract is not disclosed.
Published by HT Digital Content Services with permission from Pivotal Sources....